COSCIENS Biopharma Inc. Quarterly Research And Development Expense in USD from Q2 2018 to Q1 2024

Taxonomy & unit: ifrs-full: USD
Summary: COSCIENS Biopharma Inc. quarterly/annual Research And Development Expense history and growth rate from Q2 2018 to Q1 2024.
COSCIENS Biopharma Inc. Research And Development Expense for the quarter ending March 31, 2024 was $2.58M, a 35.6% decline year-over-year.
COSCIENS Biopharma Inc. Research And Development Expense for the twelve months ending March 31, 2024 was $12.1M, a 14.1% decline year-over-year.
COSCIENS Biopharma Inc. annual Research And Development Expense for 2023 was $13.6M, a 8.43% increase from 2022.
COSCIENS Biopharma Inc. annual Research And Development Expense for 2022 was $12.5M, a 90.2% increase from 2021.
COSCIENS Biopharma Inc. annual Research And Development Expense for 2021 was $6.57M, a 337% increase from 2020.

Research And Development Expense, Trailing 12 Months (USD)

Research And Development Expense, Quarterly (USD)

Research And Development Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	$12.1M	$2.58M	-$1.43M	-35.6%	Jan 1, 2024	Mar 31, 2024	6-K	2024-05-16
Q4 2023	$13.6M	$3.87M	-$557K	-12.6%	Oct 1, 2023	Dec 31, 2023	20-F/A	2024-07-17
Q3 2023	$14.1M	$2.75M	-$542K	-16.5%	Jul 1, 2023	Sep 30, 2023	6-K	2023-11-09
Q2 2023	$14.7M	$2.93M	+$531K	+22.1%	Apr 1, 2023	Jun 30, 2023	6-K	2023-08-09
Q1 2023	$14.1M	$4.01M	+$1.62M	+67.9%	Jan 1, 2023	Mar 31, 2023	6-K	2024-05-16
Q4 2022	$12.5M	$4.43M	+$2.56M	+138%	Oct 1, 2022	Dec 31, 2022	20-F/A	2024-07-17
Q3 2022	$9.94M	$3.29M	+$1.81M	+122%	Jul 1, 2022	Sep 30, 2022	6-K	2023-11-09
Q2 2022	$8.14M	$2.4M	+$630K	+35.6%	Apr 1, 2022	Jun 30, 2022	6-K	2023-08-09
Q1 2022	$7.51M	$2.39M	+$932K	+63.9%	Jan 1, 2022	Mar 31, 2022	6-K	2023-05-09
Q4 2021	$6.57M	$1.86M	+$1.24M	+198%	Oct 1, 2021	Dec 31, 2021	20-F/A	2024-07-17
Q3 2021	$5.34M	$1.49M	+$1.11M	+299%	Jul 1, 2021	Sep 30, 2021	6-K	2022-11-03
Q2 2021	$4.22M	$1.77M	+$1.58M	+835%	Apr 1, 2021	Jun 30, 2021	6-K/A	2022-08-04
Q1 2021	$2.65M	$1.46M	+$1.14M	+357%	Jan 1, 2021	Mar 31, 2021	6-K	2022-05-11
Q4 2020	$1.51M	$626K	+$363K	+138%	Oct 1, 2020	Dec 31, 2020	20-F/A	2024-02-15
Q3 2020	$1.14M	$372K	-$103K	-21.7%	Jul 1, 2020	Sep 30, 2020	6-K	2021-11-04
Q2 2020	$1.25M	$189K	-$382K	-66.9%	Apr 1, 2020	Jun 30, 2020	6-K	2021-08-05
Q1 2020	$1.63M	$319K	-$209K	-39.6%	Jan 1, 2020	Mar 31, 2020	6-K	2021-05-05
Q4 2019	$1.84M	$263K			Oct 1, 2019	Dec 31, 2019	20-F	2022-03-29
Q3 2019		$475K	+$117K	+32.7%	Jul 1, 2019	Sep 30, 2019	6-K	2020-11-05
Q2 2019		$571K	-$403K	-41.4%	Apr 1, 2019	Jun 30, 2019	6-K	2020-08-06
Q1 2019		$528K			Jan 1, 2019	Mar 31, 2019	6-K/A	2020-05-11
Q3 2018		$358K			Jul 1, 2018	Sep 30, 2018	6-K	2019-11-07
Q2 2018		$974K			Apr 1, 2018	Jun 30, 2018	6-K	2019-08-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.